Mickisch G - Search Results

1

The European Medicines Agency approval of axitinib (Inlyta) for the treatment of advanced renal cell carcinoma after failure of prior treatment with sunitinib or a cytokine: summary of the scientific assessment of the committee for medicinal products for human use.

Tzogani K, Skibeli V, Westgaard I, Dalhus M, Thoresen H, Slot KB, Damkier P, Hofland K, Borregaard J, Ersbøll J, Salmonson T, Pieters R, Sylvester R, Mickisch G, Bergh J, Pignatti F. Tzogani K, et al. Among authors: mickisch g. Oncologist. 2015 Feb;20(2):196-201. doi: 10.1634/theoncologist.2014-0177. Epub 2015 Jan 23. Oncologist. 2015. PMID: 25616431 Free PMC article. Review.

2

Randomized phase II/III trial of interferon Alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell Carcinoma: the European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951).

Aass N, De Mulder PH, Mickisch GH, Mulders P, van Oosterom AT, van Poppel H, Fossa SD, de Prijck L, Sylvester RJ. Aass N, et al. J Clin Oncol. 2005 Jun 20;23(18):4172-8. doi: 10.1200/JCO.2005.07.114. J Clin Oncol. 2005. PMID: 15961764 Clinical Trial.

3

Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis.

Flanigan RC, Mickisch G, Sylvester R, Tangen C, Van Poppel H, Crawford ED. Flanigan RC, et al. Among authors: mickisch g. J Urol. 2004 Mar;171(3):1071-6. doi: 10.1097/01.ju.0000110610.61545.ae. J Urol. 2004. PMID: 14767273 Free article. Clinical Trial.

4

Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-alpha2a compared with sunitinib.

Mickisch G, Gore M, Escudier B, Procopio G, Walzer S, Nuijten M. Mickisch G, et al. Br J Cancer. 2010 Jan 5;102(1):80-6. doi: 10.1038/sj.bjc.6605417. Epub 2009 Nov 17. Br J Cancer. 2010. PMID: 19920817 Free PMC article.

5

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial.

Mickisch GH, Garin A, van Poppel H, de Prijck L, Sylvester R; European Organisation for Research and Treatment of Cancer (EORTC) Genitourinary Group. Mickisch GH, et al. Lancet. 2001 Sep 22;358(9286):966-70. doi: 10.1016/s0140-6736(01)06103-7. Lancet. 2001. PMID: 11583750 Clinical Trial.

6

[Immunotherapy and tyrosine kinase inhibitors in first-line treatment of metastatic renal cell carcinoma-Which strategy when?].

Mickisch G, Peters I, Grüllich C, Mudra T, Doehn C. Mickisch G, et al. Urologe A. 2020 Dec;59(12):1504-1511. doi: 10.1007/s00120-020-01320-8. Urologe A. 2020. PMID: 33026489 Free PMC article. Review. German.

7

Indirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy.

Mickisch GH, Schwander B, Escudier B, Bellmunt J, Maroto JP, Porta C, Walzer S, Siebert U. Mickisch GH, et al. Clinicoecon Outcomes Res. 2011;3:19-27. doi: 10.2147/CEOR.S16118. Epub 2011 Jan 25. Clinicoecon Outcomes Res. 2011. PMID: 21935329 Free PMC article.

8

[Metastatic renal cell carcinoma: primary and follow-up treatment].

Steiner T, Mickisch GH. Steiner T, et al. Among authors: mickisch gh. Urologe A. 2013 Nov;52(11):1529-30, 1532-3. doi: 10.1007/s00120-013-3248-8. Urologe A. 2013. PMID: 24170300 German.

9

Interferon-alpha-2a with or without 13-cis retinoic acid in patients with progressive, measurable metastatic renal cell carcinoma.

Fosså SD, Mickisch GH, De Mulder PH, Horenblas S, van Oosterom AT, van Poppel H, Fey M, Croles JJ, de Prijck L, Van Glabbeke M. Fosså SD, et al. Cancer. 2004 Aug 1;101(3):533-40. doi: 10.1002/cncr.20307. Cancer. 2004. PMID: 15274066 Free article. Clinical Trial.

10

Treatment algorithm for metastatic renal cell carcinoma--recommendations based on evidence and clinical practice.

Bergmann L, Beck J, Bothe K, Brinkmann OA, Buse S, Goebell PJ, Grünwald V, Holzapfel K, Kübler H, Marschner NW, Mickisch G, Schultze-Seemann W, Siebels M, Siemer S, Störkel S, Gschwend JE. Bergmann L, et al. Among authors: mickisch g. Oncol Res Treat. 2014;37(3):136-41. doi: 10.1159/000360179. Epub 2014 Feb 21. Oncol Res Treat. 2014. PMID: 24685918 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

83 results

Search Page